208 related articles for article (PubMed ID: 28109000)
21. Sentinel lymph node biopsy in patients with thin melanoma: occurrence of nodal metastases and its prognostic value.
Vermeeren L; Van der Ent F; Sastrowijoto P; Hulsewé K
Eur J Dermatol; 2010; 20(1):30-4. PubMed ID: 19889594
[TBL] [Abstract][Full Text] [Related]
22. Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate.
Balch CM; Gershenwald JE; Soong SJ; Thompson JF
J Surg Oncol; 2011 Sep; 104(4):379-85. PubMed ID: 21858832
[TBL] [Abstract][Full Text] [Related]
23. The importance of mitosis ≥2 in selecting patients with T1 cutaneous melanomas for sentinel lymph node biopsy.
Borgognoni L; Crocetti E; Sestini S; Brandani P; Giannotti V; Gerlini G
Melanoma Res; 2022 Dec; 32(6):469-476. PubMed ID: 36317389
[TBL] [Abstract][Full Text] [Related]
24. More sentinel lymph node biopsies for thin melanomas after transition to AJCC 8th edition do not increase positivity rate: A Danish population-based study of 7148 patients.
Weitemeyer MB; Helvind NM; Brinck AM; Hölmich LR; Chakera AH
J Surg Oncol; 2022 Mar; 125(3):498-508. PubMed ID: 34672372
[TBL] [Abstract][Full Text] [Related]
25. Mitotic rate is a more reliable unfavorable prognosticator than ulceration for early cutaneous melanoma: a 5-year survival analysis.
Donizy P; Kaczorowski M; Leskiewicz M; Zietek M; Pieniazek M; Kozyra C; Halon A; Matkowski R
Oncol Rep; 2014 Dec; 32(6):2735-43. PubMed ID: 25310673
[TBL] [Abstract][Full Text] [Related]
26. How does the mitotic index impact patients with T1 melanoma? Comparison between the 7th and 8th edition of the American Joint Committee on Cancer melanoma staging system.
Antonialli AZ; Bertolli E; de Macedo MP; Pinto CAL; Calsavara VF; Neto JPD
An Bras Dermatol; 2020; 95(6):691-695. PubMed ID: 33008658
[TBL] [Abstract][Full Text] [Related]
27. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
28. The importance of mitosis as a factor for predicting sentinel lymph node biopsy for thin melanoma.
Oliveira Filho RS; Jorge MC; Oliveira DA; Oliveira RL; Queiroz Mdo C; Nahas FX
An Bras Dermatol; 2011; 86(4 Suppl 1):S107-9. PubMed ID: 22068786
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of incomplete sentinel node biopsy procedures and sentinel node positivity rates as surgical quality-assurance parameters in melanoma patients.
Spillane AJ; Haydu LE; Lee NC; Uren RF; Stretch JR; Shannon KF; Quinn MJ; Saw RP; McCarthy WH; Thompson JF
Ann Surg Oncol; 2012 Nov; 19(12):3919-25. PubMed ID: 22644517
[TBL] [Abstract][Full Text] [Related]
30. Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one.
Sekula-Gibbs SA; Shearer MA
Dermatol Surg; 2011 Aug; 37(8):1080-8. PubMed ID: 21635622
[TBL] [Abstract][Full Text] [Related]
31. The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study.
Oude Ophuis CM; Verhoef C; Rutkowski P; Powell BW; van der Hage JA; van Leeuwen PA; Voit CA; Testori A; Robert C; Hoekstra HJ; Grünhagen DJ; Eggermont AM; van Akkooi AC
Eur J Surg Oncol; 2016 Dec; 42(12):1906-1913. PubMed ID: 27266406
[TBL] [Abstract][Full Text] [Related]
32. Sentinel node biopsy versus elective lymph node dissection in patients with cutaneous melanoma in a Japanese population.
Tsutsumida A; Furukawa H; Yamamoto Y; Horiuchi K; Yoshida T; Minakawa H; Fujii S; Murao N; Kuwahara H; Minamimoto T; Fujioka H; Sakamoto T; Honma T
Int J Clin Oncol; 2007 Aug; 12(4):245-9. PubMed ID: 17701001
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node biopsy is prognostic but not therapeutic for thick melanoma.
Kachare SD; Singla P; Vohra NA; Zervos EE; Wong JH; Fitzgerald TL
Surgery; 2015 Sep; 158(3):662-8. PubMed ID: 26096561
[TBL] [Abstract][Full Text] [Related]
34. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
Gimotty PA; Botbyl J; Soong SJ; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8065-75. PubMed ID: 16258105
[TBL] [Abstract][Full Text] [Related]
35. Global and mitosis-specific interobserver variation in mitotic count scoring and implications for malignant melanoma staging.
Saldanha G; Ali R; Bakshi A; Basiouni A; Bishop R; Colloby P; Craig P; Da Forno P; Edward S; Espinosa de Los Monteros O; Evans A; Jamieson L; Rytina E; Bamford M
Histopathology; 2020 May; 76(6):803-813. PubMed ID: 31879972
[TBL] [Abstract][Full Text] [Related]
36. pT1 substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of malignant renal epithelial tumors.
Salama ME; Guru K; Stricker H; Peterson E; Peabody J; Menon M; Amin MB; De Peralta-Venturina M
J Urol; 2005 May; 173(5):1492-5. PubMed ID: 15821466
[TBL] [Abstract][Full Text] [Related]
37. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy.
Wagner JD; Schauwecker D; Davidson D; Coleman JJ; Saxman S; Hutchins G; Love C; Hayes JT
J Clin Oncol; 1999 May; 17(5):1508-15. PubMed ID: 10334538
[TBL] [Abstract][Full Text] [Related]
38. The magic of numbers: malignant melanoma between science and pseudoscience.
Weyers W
Am J Dermatopathol; 2011 Jun; 33(4):371-8. PubMed ID: 21478727
[TBL] [Abstract][Full Text] [Related]
39. Sentinel node biopsy in thin and thick melanoma.
Mozzillo N; Pennacchioli E; Gandini S; Caracò C; Crispo A; Botti G; Lastoria S; Barberis M; Verrecchia F; Testori A
Ann Surg Oncol; 2013 Aug; 20(8):2780-6. PubMed ID: 23720068
[TBL] [Abstract][Full Text] [Related]
40. Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage.
Teterycz P; Ługowska I; Koseła-Paterczyk H; Rutkowski P
World J Surg Oncol; 2019 Jul; 17(1):129. PubMed ID: 31345228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]